Magnetic resonance imaging of breast cancer: Clinical indications and breast MRI reporting system

Journal of Magnetic Resonance Imaging

Volumn 12, Issue 6, 2000, Pages 975-983

  Ikeda, Debra M ^a,c   Baker, Douglas R ^b   Daniel, Bruce L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast; Breast, diseases; Breast, MR; Breast, neoplasms; Magnetic resonance (MR)

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CLINICAL EXAMINATION; DIAGNOSTIC ACCURACY; ECHOMAMMOGRAPHY; HUMAN; LYMPH NODE METASTASIS; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

BREAST; BREAST NEOPLASMS; DOCUMENTATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, MAMMARY;

EID: 0033660227     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/1522-2586(200012)12:6<975::AID-JMRI24>3.0.CO;2-Y     Document Type: Article

References (104)

1. MR imaging of the breast: Comparison with mammography and ultrasound
2. MR imaging of the breast using gadolinium-DTPA
3. MR imaging of the breast with Gd-DTPA: Use and limitations
4. MR imaging of the breast: Fast imaging sequences with and without Gd-DTPA. Preliminary observations
5. MR imaging of the breast with rotating delivery of excitation off resonance: Clinical experience with pathologic correlation
6. Integration of breast magnetic resonance imaging with breast cancer treatment
7. High-resolution MR imaging of the breast: Clinical context
8. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare
9. Mammographic screening and mortality from breast cancer: The Malmo mammographic screening trial
10. Breast cancer missed by mammography
11. Interval carcinomas in the Malmo mammographic screening trial: Radiographic appearance and prognostic considerations
12. Analysis of cancers missed at screening mammography
13. Breast cancer detection demonstration project: Five-year summary report
14. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique
15. Breast tumors: Comparative accuracy of MR imaging relative to mammography and US for demonstrating extent
16. Contrast-enhanced magnetic resonance imaging of the breast
17. Gd-DTPA enhanced MR imaging of the breast in patients with postoperative scarring and silicon implants
18. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: Preliminary results in 26 patients
19. Breast disease: Tissue characterization with Gd-DTPA enhancement profiles
20. Dynamic MR mammography: A technique for potentially reducing the biopsy rate for benign breast disease
21. Magnetic resonance imaging of the breast in characterizing positive or uncertain mammographic findings
22. Clinical usefulness of MR imaging of the breast in the evaluation of the problematic mammogram
23. Solitary intraductal papilloma: Findings at MR imaging and MR galactography
24. MR imaging in patients with nipple discharge: Initial experience
25. Breast MR and the appearance of the normal and abnormal nipple
26. Serendipity in diagnostic imaging: Magnetic resonance imaging of the breast
27. Incidental enhancing lesions (IEL) detected during contrast-enhanced breast magnetic resonance (MR) imaging scans: Prevalence and clinical impact
28. Ductal carcinoma in situ: MR imaging-histopathologic correlation
29. MR imaging of ductal carcinoma in situ
30. False-negative MR imaging of malignant breast tumors
31. Nonpalpable breast tumors: Diagnosis with contrast-enhanced subtraction dynamic MR imaging
32. MR-guided biopsy of suspect breast lesions with a simple stereotaxic add-on-device for surface coils
33. Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). II. The significance of regional node histology other than sinus histiocytosis in invasive mammary cancer
34. Pathological findings from the national surgical adjuvant breast project (Protocol No. 4). IV. Significance of tumor necrosis
35. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS)
36. A biological perspective of breast cancer: Contributions of the national surgical adjuvant breast and bowel project clinical trials
37. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer
38. High risk screening working group report
39. Mammography of breast carcinoma in women who have mutations of the breast cancer gene BRCA1: Initial experience
40. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: Preliminary results
41. Breast carcinoma in women previously treated for Hodgkin's disease: Clinical and mammographic findings
42. Breast cancer in patients treated for Hodgkin's disease: Clinical and pathological analysis of 76 cases in 63 patients
43. Breast carcinoma in women previously treated for Hodgkin disease: Mammographic evaluation
44. Breast carcinoma in young women previously treated for Hodgkin disease
45. Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone
46. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually
47. Selection criteria for breast cancer chemoprevention subjects
48. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: Normal contrast medium enhancement and cyclical-phase dependency
49. Assessment of breast tissue changes on hormonal replacement therapy using MRI: A pilot study
50. The variability of fibroadenoma in contrast-enhanced dynamic MR mammography
51. Earlier detection of breast cancer by surveillance of women at familial risk
52. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer
53. Breast cancer staging working group report
54. Can intraductal breast carcinoma be excised completely by local excision? Clinical and pathologic predictors
55. Noninvasive breast carcinoma: Frequency of unsuspected invasion and implications for treatment
56. Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early stage breast carcinoma
57. New horizons in the diagnosis and treatment of breast cancer using magnetic resonance imaging
58. Breast cancer. Importance of adequate surgical excision prior to radiotherapy in the local control of breast cancer in patients treated conservatively
59. Ductal carcinoma in situ: Mammographic findings and clinical implications
60. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures
61. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ
62. Breast carcinoma: Effect of preoperative contrast-enhanced MR imaging on the therapeutic approach
63. Magnetic resonance imaging in breast cancer staging
64. Staging of suspected breast cancer: Effect of MR imaging and MR-guided biopsy
65. Utility of magnetic resonance imaging in the management of breast cancer: Evidence for improved preoperative staging
66. Three-dimensional shaded-surface rendering of MR images of the breast: Technique, applications, and impact on surgical management of breast disease
67. Evaluation of pectoralis major muscle in patients with posterior breast tumors on breast MR images: Early experience
68. Invasive lobular carcinoma: Mammographic findings in a 10-year experience
69. MR imaging in the management before surgery of lobular carcinoma of the breast: Correlation with pathology
70. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ
71. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators
72. Contrast-enhanced MRI of the breast after limited surgery and radiation therapy
73. Retrospective analysis for evaluation of the value of contrast-enhanced MRI in patients treated with breast conservative therapy
74. Magnetic resonance imaging in the diagnosis of local recurrences in breast cancer
75. Magnetic resonance imaging in potential post-surgical recurrence of breast cancer: Pitfalls and limitations
76. Occult breast carcinoma presenting as axillary metastases
77. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy
78. Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy
79. Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs
80. Combined modality treatment of stage III and inflammatory breast cancer. M.D. Anderson Cancer Center experience
81. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy
82. Breast surgery after neoadjuvant treatment. Is it necessary?
83. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging
84. Locally advanced breast cancer: Contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy
85. MRI of breast cancer: Influence of chemotherapy on sensitivity
86. Locally advanced breast cancer treated with primary chemotherapy: Comparison between magnetic resonance imaging and pathologic evaluation of residual disease
87. Changes in the findings of dynamic MRI by preoperative CAF chemotherapy for patients with breast cancer of stage II and III: Pathologic correlation
88. Lesion diagnosis working group report
89. Breast MR imaging: Interpretation model
90. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation
91. Suspect breast lesions: Findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features
92. Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions?
93. Differentiating benign from malignant enhancing lesions identified at MR imaging of the breast: Are time-signal intensity curves an accurate predictor?
94. Breast disease: Dynamic spiral MR imaging
95. Gd-DTPA contrast enhancement and tissue differentiation in MR imaging of experimental breast carcinoma
96. Characterization of breast lesion morphology with delayed 3DSSMT: An adjunct to dynamic breast MRI
97. Fibroadenomas: MR imaging appearances with radiologic-histopathologic correlation
98. Breast fibroadenoma: Mapping of pathophysiologic features with three-time-point, contrast-enhanced MR imaging-pilot study
99. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
100. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
101. Breast MR imaging with commercially available techniques: Radiologic-pathologic correlation
102. Application of a quantitative model to differentiate benign from malignant breast lesions detected by dynamic, gadolinium-enhanced MRI
103. Observer variability in the interpretation of contrast enhanced MRI of the breast
104. Interobserver variability in classification of time-signal intensity curves from contrast-enhanced breast MRI